Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · IEX Real-Time Price · USD

0.790

+0.002 (0.30%)

At close: Apr 19, 2024, 4:00 PM

0.800

+0.010 (1.25%)

After-hours: Apr 19, 2024, 7:15 PM EDT

Kezar Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	7	0	0	0	0	0	0	0
Gross Profit	7	0	0	0	0	0	0	0
Selling, General & Admin	26.54	20.15	15.72	11.97	9.98	6.59	2.28	1.62
Research & Development	85.7	51.01	38.94	30.98	27.36	18.14	6.47	7.37
Other Operating Expenses	6.19	0	0	0	0	0	0	0
Operating Expenses	118.42	71.16	54.66	42.95	37.34	24.73	8.75	8.99
Operating Income	-111.42	-71.16	-54.66	-42.95	-37.34	-24.73	-8.75	-8.99
Interest Expense / Income	1.55	1.19	0.16	0	0	0	0	0
Other Expense / Income	-11.1	-4.11	-0.19	-1.21	-2.26	-1.56	-0.23	-
Pretax Income	-101.87	-68.24	-54.63	-41.74	-35.09	-23.17	-8.52	-8.99
Net Income	-101.87	-68.24	-54.63	-41.74	-35.09	-23.17	-8.52	-8.99
Shares Outstanding (Basic)	73	67	53	44	19	10	1	0
Shares Outstanding (Diluted)	73	67	53	44	19	10	1	0
Shares Change	7.70%	27.69%	19.90%	130.58%	85.92%	1612.79%	77.07%	-
EPS (Basic)	-1.40	-1.01	-1.04	-0.95	-1.84	-2.26	-14.21	-26.56
EPS (Diluted)	-1.40	-1.01	-1.04	-0.95	-1.84	-2.26	-14.21	-26.56
Free Cash Flow	-83.45	-60.42	-42.75	-37.14	-30.48	-21.9	-8.5	-9.89
Free Cash Flow Per Share	-1.15	-0.90	-0.81	-0.84	-1.60	-2.13	-14.18	-29.23
Gross Margin	100.00%	-	-	-	-	-	-	-
Operating Margin	-1591.77%	-	-	-	-	-	-	-
Profit Margin	-1455.29%	-	-	-	-	-	-	-
Free Cash Flow Margin	-1192.14%	-	-	-	-	-	-	-
EBITDA	-99.25	-66.03	-52.96	-40.2	-33.79	-22.48	-8.34	-8.84
EBITDA Margin	-1417.91%	-	-	-	-	-	-	-
Depreciation & Amortization	1.07	1.02	1.51	1.54	1.3	0.69	0.18	0.15
EBIT	-100.32	-67.05	-54.47	-41.74	-35.09	-23.17	-8.52	-8.99
EBIT Margin	-1433.14%	-	-	-	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).